Literature DB >> 26167352

Aripiprazole Induced Acute Transient Bilateral Myopia: A Case Report.

Hasan Karadağ1, Mutlu Acar2, Kadir Özdel1.   

Abstract

BACKGROUND: Aripiprazole is an atypical antipsychotic drug. Acute transient myopia is a rare response to systemic medication. Unspecified ocular side effects of aripiprazole have rarely been reported. To the best of our knowledge, only 3 cases of aripiprazole induced myopia and diplopia have been reported in the literature. The aim of this article is to present a case of aripiprazole-induced acute transient myopia. CASE REPORT: A 30 year-old woman underwent treatment for 5 days with aripiprazole and presented with bilateral painless blurred vision. The patient's uncorrected visual acuity was 2/10 in both eyes and her best corrected visual acuity was 10/10 in both eyes with a refractive error of -3.00 diopters using a standard Snellen chart. Adding 2 mgs of biperiden a day to her treatment regimen decreased her blurred vision symptoms. After discontinuation of aripiprazole treatment and cross-switching to Paliperidon palmitate (75 mg/month) her blurred vision completely resolved. The same side effect did not re-occur when checked on her 6-month follow up.
CONCLUSION: Ophthalmologists as well as psychiatrists must be aware of this myopic shift and should also ask these patients about medicine usage, especially aripiprazole. Ophthalmologists should consult the prescribing psychiatrist and stop the drug immediately to reverse this temporary condition.

Entities:  

Keywords:  Aripiprazole; drug induced; myopia; transient

Year:  2015        PMID: 26167352      PMCID: PMC4432708          DOI: 10.5152/balkanmedj.2015.15292

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  9 in total

1.  Aripiprazole induced transient myopia: a case report and review of literature.

Authors:  Akshay Gopinathan Nair; Aditya Gopinathan Nair; Ronnie Jacob George; Jyotirmay Biswas; Rashmin Anilkumar Gandhi
Journal:  Cutan Ocul Toxicol       Date:  2011-08-10       Impact factor: 1.820

2.  Acetazolamide-induced myopia at altitude.

Authors:  Piotr Szawarski; Beth Hall-Thompson
Journal:  Wilderness Environ Med       Date:  2009       Impact factor: 1.518

3.  Aripiprazole-related acute transient myopia and diplopia: a case report.

Authors:  Yavuz Selvi; Abdullah Atli; Adem Aydin; Halil Ibrahim Yener
Journal:  J Clin Psychopharmacol       Date:  2011-04       Impact factor: 3.153

Review 4.  Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.

Authors:  Tracy Swainston Harrison; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Transient acute myopia induced by antilymphocyte globulins.

Authors:  D Milea; C Zech; C Dumontet; B Coiffier; C Trepsat
Journal:  Ophthalmologica       Date:  1999       Impact factor: 3.250

6.  Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

Authors:  David A Shapiro; Sean Renock; Elaine Arrington; Louis A Chiodo; Li-Xin Liu; David R Sibley; Bryan L Roth; Richard Mailman
Journal:  Neuropsychopharmacology       Date:  2003-05-21       Impact factor: 7.853

7.  Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

Authors:  Robert M Berman; Maurizio Fava; Michael E Thase; Madhukar H Trivedi; René Swanink; Robert D McQuade; William H Carson; David Adson; Leslie Taylor; James Hazel; Ronald N Marcus
Journal:  CNS Spectr       Date:  2009-04       Impact factor: 3.790

8.  The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Robert M Berman; Ronald N Marcus; René Swanink; Robert D McQuade; William H Carson; Patricia K Corey-Lisle; Arif Khan
Journal:  J Clin Psychiatry       Date:  2007-06       Impact factor: 4.384

9.  Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.

Authors:  Kevin D Burris; Thaddeus F Molski; Cen Xu; Elaine Ryan; Katsura Tottori; Tetsuro Kikuchi; Frank D Yocca; Perry B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

  9 in total
  2 in total

1.  Aripiprazole-induced transient myopia: A rare entity.

Authors:  K V Praveen Kumar; P Chiranjeevi; Md Shahid Alam
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

2.  Aripiprazole-Induced Acute Transient Bilateral Myopia: A Case Report.

Authors:  Yunus Bulgu; Selim Genc
Journal:  Beyoglu Eye J       Date:  2020-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.